These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats. Lando P, Berzins K, Gabriel J, Larsson P, Perlmann P. Br J Cancer; 1981 Oct 20; 44(4):522-31. PubMed ID: 7295508 [Abstract] [Full Text] [Related]
28. Immunogenicity of embryonic antigens associated with chemically induced rat tumours. Baldwin RW, Glaves D, Vose BM. Int J Cancer; 1974 Jan 15; 13(1):135-42. PubMed ID: 4361915 [No Abstract] [Full Text] [Related]
29. Subpopulations of multiparous rat lymph-node cells cytotoxic for rat tumour cells and capable of suppressing cytotoxicity in vitro. Rees RC, Bray J, Robins RA, Baldwin RW. Int J Cancer; 1975 May 15; 15(5):762-72. PubMed ID: 166946 [Abstract] [Full Text] [Related]
30. Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma. Baldwin RW, Moore M. Int J Cancer; 1969 Nov 15; 4(6):753-60. PubMed ID: 4314170 [No Abstract] [Full Text] [Related]
31. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures. Lando P, Gabriel J, Berzins K, Perlmann P. Scand J Immunol; 1982 Mar 15; 15(3):259-66. PubMed ID: 7089487 [Abstract] [Full Text] [Related]
32. Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas. Baldwin RW, Embleton MJ. Int J Cancer; 1971 Jan 15; 7(1):17-25. PubMed ID: 4322936 [No Abstract] [Full Text] [Related]
33. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours. Zöller M, Price MR, Baldwin RW. Br J Cancer; 1977 Jun 15; 35(6):834-43. PubMed ID: 194618 [Abstract] [Full Text] [Related]
34. Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites. Höffken K, Price MR, McLaughlin PJ, Moore VE, Baldwin RW. Int J Cancer; 1978 Apr 15; 21(4):496-504. PubMed ID: 208985 [Abstract] [Full Text] [Related]
35. Serological aspects of rat tumour xenograft growth in athymic nude mice. Pimm MV, Baldwin RW. Br J Cancer; 1979 Feb 15; 39(2):116-21. PubMed ID: 373782 [Abstract] [Full Text] [Related]
36. A tumor-specific cytotoxic and neutralizing factor in rats immunized with ascites hepatoma induced by azo dyes. El-Asfahani AM, Mizuno D, Hashimoto Y, Ishidate M, Nishioka K. Gan; 1975 Feb 15; 66(1):11-9. PubMed ID: 168113 [Abstract] [Full Text] [Related]
37. Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata. Thomson DM, Eccles S, Alexander P. Br J Cancer; 1973 Jul 15; 28(1):6-15. PubMed ID: 4579634 [Abstract] [Full Text] [Related]
39. Tumour antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with beta 2 microglobulin. Bowen JG, Baldwin RW. Int J Cancer; 1979 Jun 15; 23(6):833-9. PubMed ID: 89102 [Abstract] [Full Text] [Related]
40. Cytolytic activity in vitro of lymph node cells after exposure in vivo to tumor cells suspended in blocking sera. Miller FR, Blazkovec AA. Immunol Commun; 1979 Jun 15; 8(2):193-202. PubMed ID: 220179 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]